LifeLoc Technologies Inc (LCTC)

[pdicamillo1]

Highlights from shareholder letter:

We have sharpened our product development focus to fewer, higher value projects with aggressive timelines that will make a substantial contribution to our future success.

Our financial stability has never been better, with a strong cash position and our only long-term debt being the mortgage on our building.

2016 Financial Highlights:

-Net Income increased 53% from $433,151 in 2016 from $282,254.
-Fully diluted earnings per share increased to $0.17 per share from $0.11 per share.
-Cash and cash equivalents grew by 17% to $3.772 million.
-Net Revenue declined by 5% to $8.381 million.

We are confident that we are putting in place the tools to grow.

With the increasing legalization of marijuana, the need to identify impairment in drivers and workers becomes ever more important.

As with alcohol, real time detection of marijuana and other drugs remains an enormous market need. In pursuit of that goal, we have
explored many methods of trace THC detection.

As a result of a cooperative research and development agreement with Sandia National Laboratories, we have signed an exclusive licensing agreement for the commercialization of SpinDx in the field of drugs of abuse. SpinDx has been demonstrated to detect the very low concentrations of THC, cocaine, and methamphetamine to identify impairment. We believe that the SpinDx methodology is the best detection method available and it will be the detection portion of our marijuana breathalyzer system. We look forward to the day that we can deliver to the market tools that quickly identify intoxication by marijuana and other drugs.